A detailed history of Ever Source Wealth Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 19,436 shares of NVO stock, worth $1.7 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
19,436
Previous 23,798 18.33%
Holding current value
$1.7 Million
Previous $3.4 Million 31.86%
% of portfolio
0.16%
Previous 0.23%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$119.07 - $145.42 $519,383 - $634,322
-4,362 Reduced 18.33%
19,436 $2.31 Million
Q2 2024

Aug 13, 2024

BUY
$122.71 - $146.91 $250,082 - $299,402
2,038 Added 9.37%
23,798 $3.4 Million
Q1 2024

Jun 11, 2024

BUY
$102.11 - $135.92 $2,144 - $2,854
21 Added 0.1%
21,760 $2.79 Million
Q4 2023

Feb 09, 2024

SELL
$87.78 - $105.45 $5,705 - $6,854
-65 Reduced 0.3%
21,739 $2.25 Million
Q3 2023

Nov 03, 2023

BUY
$90.94 - $199.54 $993,701 - $2.18 Million
10,927 Added 100.46%
21,804 $1.98 Million
Q2 2023

Aug 04, 2023

BUY
$155.98 - $172.65 $1.15 Million - $1.27 Million
7,341 Added 207.61%
10,877 $1.76 Million
Q1 2023

May 11, 2023

SELL
$132.34 - $159.14 $15,351 - $18,460
-116 Reduced 3.18%
3,536 $562,000
Q4 2022

Feb 09, 2023

SELL
$102.55 - $135.33 $111,471 - $147,103
-1,087 Reduced 22.94%
3,652 $494,000
Q3 2022

Nov 07, 2022

BUY
$95.28 - $116.93 $23,153 - $28,413
243 Added 5.4%
4,739 $472,000
Q2 2022

Aug 01, 2022

BUY
$103.24 - $121.81 $188,206 - $222,059
1,823 Added 68.2%
4,496 $502,000
Q1 2022

May 25, 2022

BUY
$93.1 - $112.54 $182,755 - $220,916
1,963 Added 276.48%
2,673 $297,000
Q4 2021

Feb 07, 2022

BUY
$95.88 - $117.08 $68,074 - $83,126
710 New
710 $80,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Ever Source Wealth Advisors, LLC Portfolio

Follow Ever Source Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.